0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Adenocarcinoma of the Esophagus With and Without Barrett Mucosa—Invited Critique

Jeffrey H. Peters, MD
Arch Surg. 2000;135(7):836. doi:10.1001/archsurg.135.7.836.
Text Size: A A A
Published online

Extract

The change in esophageal carcinoma from predominantly squamous carcinoma associated with tobacco and alcohol use to predominantly adenocarcinoma associated with reflux has to be one of the most dramatic epidemiologic shifts in human neoplasia. Despite a heightened awareness, we have only begun our understanding of the pathophysiology of this disease. The study by Sabel et al addresses the long-standing controversy of whether all adenocarcinomas of the esophagus arise within the Barrett epithelium and thus progress through a metaplasia, dysplasia, carcinoma sequence. Unfortunately, the tools presently available to answer this question are crude, namely, demographic and symptomatic differences and comparison of survival statistics. The authors have compared these parameters in patients with esophageal adenocarcinoma with and without surrounding Barrett epithelium. The primary findings of this study were a surprisingly low prevalence of reflux-related symptoms, both with and without identifiable Barrett epithelium; smaller and earlier-stage tumors in patients with identifiable Barrett epithelium; and no significant difference in survival stage for stage. These findings can be readily explained without the need to conclude that there are pathophysiologic differences. The presence of symptoms is proportional to the diligence with which they are looked for, the type of symptoms attributed to reflux (such as asthma and cough), and the fact that patients often minimize reflux symptoms in the presence of new ones related to the cancer. The likelihood that larger tumors overgrow the area of Barrett epithelium confounds this and similar studies, and is unavoidable. Dividing the study groups based on criteria present in the tissue surrounding the tumor can be expected, by chance alone, to result in the absence of the criteria given large tumors. The authors do not give us insight into whether any of the patients who had BE were enrolled in a surveillance program, although it seems unlikely that none of the 66 would have been. If so, this would also result in earlier-stage tumors in the BE group. They conclude that all esophageal adenocarcinomas arise in Barrett epithelium. This is almost certainly true, although proof is lacking. A better understanding of the genetic events leading to BE and its neoplastic progression will one day answer the question.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();